BlueCrest Capital Finance

BlueCrest Capital Finance was a prominent venture debt firm that specialized in providing growth capital to late-stage venture-backed companies, with a particular emphasis on the life sciences and healthcare technology sectors. As a subsidiary of BlueCrest Capital Management, the firm offered flexible debt financing solutions designed to minimize equity dilution for emerging biotech and medical device companies. In January 2015, the platform was acquired by TriplePoint Capital, a leading global investment corporation. During its tenure, BlueCrest Capital Finance was a significant participant in the healthcare innovation economy, funding numerous companies through their clinical development phases. The acquisition by TriplePoint included the transfer of the investment team and the existing loan portfolio.